Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns

• Main Authors: Danielle Dauchot, PharmD (Author), Suzanne Rettey, PharmD, MPA, BCPP (Author), Brittany L. Melton, PharmD, PhD (Author), Karen E. Moeller, PharmD, BCPP (Author)
• Formato: Livro
• Publicado em: American Association of Psychiatric Pharmacists, 2024-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction Depression rates in children/adolescents in the United States have increased in the last 10 years. Fluoxetine and escitalopram are the only 2 antidepressants approved for the treatment of major depression disorder (MDD) in children/adolescents. In adults, some antipsychotics are approve...